RAFAEL
ARROYO GONZALEZ
PROFESOR
Charles University in Prague
Praga, República ChecaPublicaciones en colaboración con investigadores/as de Charles University in Prague (2)
2020
-
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS Studies
Neurology and Therapy, Vol. 9, Núm. 2, pp. 443-457
2017
-
Alemtuzumab improves quality-of-life outcomes compared with subcutaneous interferon beta-1a in patients with active relapsing-remitting multiple sclerosis
Multiple Sclerosis, Vol. 23, Núm. 10, pp. 1367-1376